Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
GSK PLC Sponsored ADR (GSK) had Free Cash Flow per Share of $4.11 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$43.08B |
|
$7.54B |
|
$11.89B |
|
$31.19B |
|
$32.62B |
|
$10.46B |
|
$-700.23M |
|
$9.76B |
|
$9.76B |
|
$8.29B |
|
$8.29B |
|
$8.29B |
|
$8.29B |
|
$10.46B |
|
$13.51B |
|
2.03B |
|
2.06B |
|
$3.72 |
|
$3.66 |
|
| Balance Sheet Financials | |
$23.09B |
|
$12.29B |
|
$57.51B |
|
$80.60B |
|
$28.21B |
|
$19.40B |
|
$31.35B |
|
$59.56B |
|
$21.04B |
|
$-10.30B |
|
$21.04B |
|
2.16B |
|
| Cash Flow Statement Financials | |
$10.21B |
|
$-5.58B |
|
$-4.86B |
|
$4.49B |
|
$4.23B |
|
$-258.47M |
|
$493.19M |
|
$-3.38B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
0.48 |
|
1.11 |
|
72.40% |
|
24.28% |
|
24.28% |
|
31.36% |
|
22.66% |
|
17.50% |
|
$8.46B |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
1.52 |
|
4.21 |
|
86.69 |
|
39.41% |
|
-80.53% |
|
10.29% |
|
20.51% |
|
$9.75 |
|
|
Free Cash Flow per Share |
$4.11 |
$4.96 |
|